Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Carbamazepine Efficacy in Moderate Persistent and Severe Asthma Therapy

NCT00153296 is registered in ClinicalTrials.gov with Centre of Chinese Medicine, Georgia as lead sponsor.

NCT NCT00153296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00153296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Carbamazepine Efficacy in Moderate Persistent and Severe Asthma Therapy
Lead sponsor
Centre of Chinese Medicine, Georgia
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2004
Completion date
April 30, 2005
Enrollment
68
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial asthma